We are live on ! Find out more
TOCUITCONY

Trustees of Columbia University in the City of New York Portfolio holdings

AUM $891M
1-Year Est. Return 17.3%
This Fund
S&P 500
This Quarter Est. Return
+0.29%
1 Year Est. Return
+17.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$82.5M
AUM Growth
+$7.66M
Cap. Flow
+$12.9M
Cap. Flow %
15.58%
Top 10 Hldgs %
96.13%
Holding
20
New
7
Increased
Reduced
4
Closed
3

Top Sells

Rank Stock Value
1
KYMR icon
Kymera Therapeutics
KYMR
+$9.04M
2
GBIO
Generation Bio
GBIO
+$8.87M
3
MCRB icon
Seres Therapeutics
MCRB
+$1.47M
4
PGNY icon
Progyny
PGNY
+$718K
5
ASAN icon
Asana
ASAN
+$609K

Sector Composition

Rank Sector Weight
1 Healthcare 41.18%
2 Financials 36.81%
3 Industrials 15.89%
4 Technology 4.37%
5 Consumer Discretionary 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.A icon
1
Berkshire Hathaway Class A
BRK.A
$1.08T
$30.1M 36.46%
78
ACCD
2
DELISTED
Accolade Inc
ACCD
$13.1M 15.89%
+288,892
New +$13.9M
KYMR icon
3
Kymera Therapeutics
KYMR
$9.49B
$12.2M 14.75%
313,127
-150,171
-32% -$9.04M
SANA icon
4
Sana Biotechnology
SANA
$1.1B
$9.41M 11.41%
+281,250
New +$9.16M
VOR icon
5
Vor Biopharma
VOR
$1.36B
$7.92M 9.6%
+9,191
New +$7.78M
RAPT
6
DELISTED
RAPT Therapeutics
RAPT
$1.63M 1.97%
9,173
CMRC
7
Commerce.com Inc Series 1
CMRC
$180M
$1.45M 1.76%
+25,065
New +$1.67M
EVLO
8
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$1.22M 1.48%
5,693
KLDO
9
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$1.22M 1.47%
150,150
MSFT icon
10
Microsoft
MSFT
$3.67T
$1.1M 1.34%
4,678
DASH icon
11
DoorDash
DASH
$93B
$923K 1.12%
+7,040
New +$1.18M
ASAN icon
12
Asana
ASAN
$2.02B
$581K 0.7%
20,327
-17,643
-46% -$609K
TWLO icon
13
Twilio
TWLO
$38.8B
$470K 0.57%
1,380
-1,315
-49% -$493K
AR icon
14
Antero Resources
AR
$11.4B
$425K 0.52%
+41,633
New +$353K
PGNY icon
15
Progyny
PGNY
$2B
$411K 0.5%
9,224
-15,373
-62% -$718K
BRK.B icon
16
Berkshire Hathaway Class B
BRK.B
$1.09T
$282K 0.34%
1,100
AM icon
17
Antero Midstream
AM
$10.5B
$101K 0.12%
+11,130
New +$95.9K
GBIO
18
DELISTED
Generation Bio
GBIO
-31,288
Closed -$8.87M
MCRB icon
19
Seres Therapeutics
MCRB
$44.9M
-2,997
Closed -$1.47M
RBBN icon
20
Ribbon Communications
RBBN
$381M
-13,085
Closed -$86K

Similar funds

Trustees of Columbia University in the City of New York's Q1 2021 Portfolio in Review

As of Q1 2021, Trustees of Columbia University in the City of New York held 20 positions worth $82.5M, up 10% from $74.8M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Trustees of Columbia University in the City of New York deployed $12.9M of net new capital in Q1 2021, opening 7 new positions. Its largest new stake was Accolade Inc: 288,892 shares worth $13.1M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 59% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Kymera Therapeutics, an estimated $9.04M trimmed.

  • Trustees of Columbia University in the City of New York's largest Q1 2021 buy was Accolade Inc: 288,892 shares worth $13.1M.
  • Trustees of Columbia University in the City of New York's biggest Q1 2021 reduction was Kymera Therapeutics, cutting an estimated $9.04M.
  • Trustees of Columbia University in the City of New York fully exited Generation Bio in Q1 2021, selling an estimated $8.87M.
  • Trustees of Columbia University in the City of New York's ten largest holdings make up 96% of its $82.5M portfolio in Q1 2021.
  • Trustees of Columbia University in the City of New York opened 7 new positions and closed 3 in Q1 2021.
  • Trustees of Columbia University in the City of New York's portfolio value rose 10% quarter-over-quarter to $82.5M.

Based on Trustees of Columbia University in the City of New York's 13F filing for Q1 2021, filed 17 May 2021.